Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthcare Triangle (HCTI) Cash & Equivalents (2020 - 2025)

Healthcare Triangle's Cash & Equivalents history spans 6 years, with the latest figure at $1.6 million for Q3 2025.

  • For Q3 2025, Cash & Equivalents rose 5717.86% year-over-year to $1.6 million; the TTM value through Sep 2025 reached $1.6 million, up 5717.86%, while the annual FY2024 figure was $20000.0, 98.38% down from the prior year.
  • Cash & Equivalents for Q3 2025 was $1.6 million at Healthcare Triangle, down from $3.2 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $6.8 million in Q1 2025 and bottomed at $20000.0 in Q4 2024.
  • The 5-year median for Cash & Equivalents is $719000.0 (2021), against an average of $1.2 million.
  • The largest annual shift saw Cash & Equivalents crashed 98.38% in 2024 before it surged 11031.03% in 2025.
  • A 5-year view of Cash & Equivalents shows it stood at $719000.0 in 2021, then decreased by 9.32% to $652000.0 in 2022, then soared by 89.26% to $1.2 million in 2023, then plummeted by 98.38% to $20000.0 in 2024, then skyrocketed by 8045.0% to $1.6 million in 2025.
  • Per Business Quant, the three most recent readings for HCTI's Cash & Equivalents are $1.6 million (Q3 2025), $3.2 million (Q2 2025), and $6.8 million (Q1 2025).